Discover how AI is transforming travel experiences in our latest podcast episode.
Author: Elyse Christian
STORM Therapeutics introduces groundbreaking RNA modification techniques to advance cancer treatment options.
ONWARD Medical is innovating neurotechnology to restore movement for spinal cord injury patients.
STORM Therapeutics raises $56 million for Phase 2 trials of STC-15, the first METTL3 inhibitor targeting rare sarcoma cancers.
BioLamina, a Stockholm-based BioTech firm, has secured a €20 million financing to advance its matrix biology and cell culture technologies.
CamGraPhIC receives €211 million funding approval from the European Commission to advance 2D photonics research.
EVANIUM has successfully raised €2.2 million to enhance its OPTISOLV® drug delivery technology.
A US science and technology council report outlines how Washington is quietly rewriting its industrial strategy to compete in chips, clean energy and critical tech.
WeRoad COO Andrea Lamperini will speak at the EU-Startups Summit 2026, sharing hands-on lessons on scaling a fast-growing travel startup across Europe.
NASA’s Artemis program and a future SpaceX IPO are set to unlock a new wave of startups and investors across the rapidly expanding $1.8 trillion space economy.